All In Biotech

Drug Trial Radar · NCT03882970

A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes

A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes

Last checked: Nov 20, 2026Latest source record: Jan 19, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,444 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,444

Actual

Start

Apr 1, 2019

Primary completion

Dec 11, 2020

Study completion Jan 4, 2021

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Mar 20, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the effect of the study drug tirzepatide to insulin degludec on blood sugar levels in participants with type 2 diabetes. The study will last about 67 weeks and may include up to 22 visits.

Conditions

  • Type 2 Diabetes Mellitus

Interventions

  • TirzepatideDrug

    Administered SC

  • Insulin DegludecDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Hemoglobin A1c (HbA1c) (10 mg and 15 mg)Time frame: Baseline, Week 52

Locations

122 sites in 13 countries. Site status is shown where the registry gives one.

  • Arkansas Clinical Research

    Little Rock, Arkansas

  • Valley Research

    Fresno, California

  • National Research Institute

    Huntington Park, California

  • National Research Institute

    Los Angeles, California

  • Catalina Research Institute, LLC

    Montclair, California

  • Valley Clinical Trials, Inc.

    Northridge, California

  • National Research Institute

    Panorama City, California

  • Encompass Clinical Research

    Spring Valley, California

  • University Clinical Investigators, Inc.

    Tustin, California

  • Chase Medical Research, LLC

    Waterbury, Connecticut

  • Indago Research & Health Center, Inc.

    Hialeah, Florida

  • East Coast Clinical Research

    Jacksonville, Florida

  • East Coast Institute For Research

    Jacksonville, Florida

  • Bayside Clinical Research, LLC

    New Port Richey, Florida

  • East Coast Institute For Research

    Macon, Georgia

  • Sky Clinical Research Network

    Union City, Georgia

  • Elite Clinical Trials LLLP

    Blackfoot, Idaho

  • Humphreys Diabetes Center

    Boise, Idaho

  • Rocky Mountain Diabetes and Osteoporosis Center

    Idaho Falls, Idaho

  • Springfield Diabetes & Endocrine Center

    Springfield, Illinois

  • Crescent City Clinical Research

    Metairie, Louisiana

  • Endocrine and Metabolic Consultants

    Rockville, Maryland

  • Troy Internal Medicine, PC

    Troy, Michigan

  • International Diabetes Center

    Minneapolis, Minnesota

  • Clinical Research Professionals

    Chesterfield, Missouri

  • Palm Research Center

    Las Vegas, Nevada

  • Palm Research Center

    Las Vegas, Nevada

  • Aventiv Research

    Columbus, Ohio

  • The Corvallis Clinic P.C.

    Corvallis, Oregon

  • Heritage Valley Medical Group, Inc.

    Beaver, Pennsylvania

  • Detweiler Family Medicine

    Lansdale, Pennsylvania

  • Office of Dr. Osvaldo Brusco

    Corpus Christi, Texas

  • Consano Clinical Research

    Shavano Park, Texas

  • AXISMED SRL - Bioclinica Research Network

    Buenos Aires, Argentina

  • Centro Médico Viamonte

    Ciudad Autonoma de Buenos Aire, Argentina

  • Instituto Centenario

    Ciudad Autonoma de Buenos Aire, Argentina

  • CENUDIAB

    Ciudad Autonoma de Buenos Aire, Argentina

  • Investigaciones Medicas IMOBA S.R.L.

    Caba, Buenos Aires, Argentina

  • CEDIC-Centro de Investigaciones Clinicas

    Caba, Buenos Aires, Argentina

  • Mautalen Salud e Investigación - Servicio de Endocrinología

    CABA, Buenos Aires, Argentina

Showing 40 of 122 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.